27 results
8-K
EX-99.1
CRBU
Caribou Biosciences Inc
29 Sep 21
Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng
4:15pm
therapies, mRNA, and other novel modalities to enable and accelerate drug development and biomedical innovation. Prior to joining Landmark Bio earlier
8-K
EX-99.1
CRBU
Caribou Biosciences Inc
8 Nov 21
Caribou Biosciences Appoints Dara Richardson-Heron, M.D., to its Board of Directors and Ruhi Khan as Chief Business Officer
9:10am
to serve on Caribou’s Board as the company drives innovation in an exciting new field of medicine,” said Dr. Richardson-Heron. “I am excited to be part
DEFA14A
CRBU
Caribou Biosciences Inc
11 Aug 22
Additional proxy soliciting materials
4:06pm
of experience and valuable public company expertise to advise and drive innovation as we execute on our mission. Caribou’s board of directors now
DRS
EX-10.54
CRBU
Caribou Biosciences Inc
7 May 21
Draft registration statement
12:00am
Name:
Andrew Acker
Title:
Authorized Signatory
Janus Henderson Biotech Innovation Master Fund Limited
By: Janus Capital Management LLC, its … .
INVESTOR:
HEALTHCARE INNOVATION INVESTMENT FUND LLC
By:
/s/ Joseph R. Gentile
Name:
Joseph R. Gentile
Title:
Manager
IN WITNESS WHEREOF, the parties
S-1
EX-10.62
CRBU
Caribou Biosciences Inc
1 Jul 21
IPO registration
4:05pm
Name:
Andrew Acker
Title:
Authorized Signatory
Janus Henderson Biotech Innovation Master Fund Limited
By: Janus Capital Management LLC, its … .
INVESTOR:
HEALTHCARE INNOVATION INVESTMENT FUND LLC
By:
/s/ Joseph R. Gentile
Name:
Joseph R. Gentile
Title:
Manager
IN WITNESS WHEREOF, the parties
DRS
EX-10.52
rll q729a
7 May 21
Draft registration statement
12:00am
S-1
EX-10.60
3apcrg2
1 Jul 21
IPO registration
4:05pm
DRS
j358335f2nc
7 May 21
Draft registration statement
12:00am
S-1/A
6qxric2
19 Jul 21
IPO registration (amended)
6:09am
S-1
at5ikys si64m0ze
1 Jul 21
IPO registration
4:05pm
424B4
mlzlyrgqtj60 xg
23 Jul 21
Prospectus supplement with pricing info
4:24pm
DRS/A
owkhm
11 Jun 21
Draft registration statement (amended)
12:00am
DRS
EX-10.51
z3bvit n0r
7 May 21
Draft registration statement
12:00am
S-1
EX-10.59
0cw snrf7y
1 Jul 21
IPO registration
4:05pm
DRS
EX-4.2
syhb8h3ecrm92uftkmy
7 May 21
Draft registration statement
12:00am
S-1
EX-4.1
lqukm19 0jypxepr
1 Jul 21
IPO registration
4:05pm
10-K
pjm9e66p34li r1jt1k
21 Mar 22
Annual report
4:19pm
ARS
kwa3ops
25 Apr 24
Annual report to shareholders
4:06pm